Literature DB >> 21857427

Legg-Calvé-Perthes disease at 100: a review of evidence-based treatment.

John Anthony Herring1.   

Abstract

BACKGROUND: The year 2010 is the 100th anniversary of the publication of the first 3 reports describing Legg- Calve-Perthes disease (LCPD). This paper summarizes available evidence previously published and discussed at the several world conferences honoring the occasion.
METHODS: Relevant articles with evidence-based data regarding the efficacy of treatment methods for LCPD were reviewed by the author.
RESULTS: The reviewed studies noted 3 factors related to outcome in patients treated for LCPD as follows: the age at onset, the classification of severity of femoral head involvement, and the type of treatment. In patients over age 8 at onset, surgical treatment with femoral varus osteotomy or Salter innominate osteotomy was associated with improved Stulberg outcomes compared with nonoperative treatment, in those who had lateral pillar B or B/C border class involvement. In the Wiig et al study, patients over age 6 with Catterall 3, 4 classification had better outcomes with these surgical treatment methods compared with nonoperative methods. Children under age 6 at onset had a good prognosis except for a small number of patients between age 4 and 6 years with lateral pillar C involvement.
CONCLUSIONS: There is valid evidence of an association between surgical treatment of certain patients with LCPD and improved radiographic outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21857427     DOI: 10.1097/BPO.0b013e318223b52d

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  16 in total

1.  What are the Demographics and Epidemiology of Legg-Calvé-Perthes Disease in a Large Southern California Integrated Health System?

Authors:  Jeffrey I Kessler; Peter C Cannamela
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

2.  Triple osteotomy of the pelvis for Legg-Calve-Perthes disease: a mean fifteen year follow-up.

Authors:  Régis Pailhé; Etienne Cavaignac; Jérôme Murgier; Jean Philippe Cahuzac; Jerôme Sales de Gauzy; Franck Accadbled
Journal:  Int Orthop       Date:  2015-02-03       Impact factor: 3.075

3.  Comparison between innominate osteotomy and arthrodistraction as a primary treatment for Legg-Calvé-Perthes disease: a prospective controlled trial.

Authors:  José Batista Volpon
Journal:  Int Orthop       Date:  2012-07-19       Impact factor: 3.075

Review 4.  Evolution in diagnosis and treatment of Legg-Calve-Perthes disease.

Authors:  Seyed Mahdi Mazloumi; Mohammad H Ebrahimzadeh; Amir Reza Kachooei
Journal:  Arch Bone Jt Surg       Date:  2014-06-15

5.  Statistical shape modeling of proximal femoral shape deformities in Legg-Calvé-Perthes disease and slipped capital femoral epiphysis.

Authors:  E F Chan; C L Farnsworth; J A Koziol; H S Hosalkar; R L Sah
Journal:  Osteoarthritis Cartilage       Date:  2012-12-26       Impact factor: 6.576

Review 6.  Do femoral or salter innominate osteotomies improve femoral head sphericity in Legg-Calvé-Perthes disease? A meta-analysis.

Authors:  Neil Saran; Renjit Varghese; Kishore Mulpuri
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

7.  Predictors of radiographic outcomes of conservative and surgical treatment of Legg-Calvé-Perthes disease.

Authors:  Andrej Stančák; Jakub Kautzner; Petr Chládek; Ondřej Adamec; Vojtěch Havlas; Tomáš Trč
Journal:  Int Orthop       Date:  2022-09-29       Impact factor: 3.479

8.  Total hip arthroplasty for the sequelae of Legg-Calvé-Perthes disease.

Authors:  Yaser M K Baghdadi; A Noelle Larson; Anthony A Stans; Tad M Mabry
Journal:  Clin Orthop Relat Res       Date:  2013-04-30       Impact factor: 4.176

Review 9.  [Legg-Calvé-Perthes disease (LCPD). Principles of diagnosis and treatment].

Authors:  M Manig
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

Review 10.  Surgical Treatments for Legg-Calvé-Perthes Disease: Comprehensive Review.

Authors:  Arash Maleki; Seyyed Mohammad Qoreishy; Mohammad Nabi Bahrami
Journal:  Interact J Med Res       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.